Senicapoc

From Wikipedia, the free encyclopedia

Page Template:Chembox/styles.css has no content.

Template:Chembox IndexlistTemplate:Chembox CompToxTemplate:Chembox Datapage check
Senicapoc
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
Names
Preferred IUPAC name
2,2-Bis(4-fluorophenyl)-2-phenylacetamide
Identifiers
Page Template:Plainlist/styles.css has no content.
3D model (JSmol)
 Page Template:Plainlist/styles.css has no content.
ChemSpider Page Template:Plainlist/styles.css has no content.
EC Number Page Template:Plainlist/styles.css has no content.
Page Template:Plainlist/styles.css has no content.
KEGG Page Template:Plainlist/styles.css has no content.
Page Template:Plainlist/styles.css has no content.
RTECS number Page Template:Plainlist/styles.css has no content.
UNII Page Template:Plainlist/styles.css has no content.
  • InChI=1S/C20H15F2NO/c21-17-10-6-15(7-11-17)20(19(23)24,14-4-2-1-3-5-14)16-8-12-18(22)13-9-16/h1-13H,(H2,23,24) ☒N
    Key: SCTZUZTYRMOMKT-UHFFFAOYSA-N ☒N
  • InChI=1/C20H15F2NO/c21-17-10-6-15(7-11-17)20(19(23)24,14-4-2-1-3-5-14)16-8-12-18(22)13-9-16/h1-13H,(H2,23,24)
    Key: SCTZUZTYRMOMKT-UHFFFAOYAR
  • C1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C(=O)N
Properties
C20H15F2NO
Molar mass 323.34 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Template:Chembox Footer/trackingTemplate:Short description

Senicapoc (ICA-17043) is a Gardos channel blocker.[1][2]

It has been proposed for use in sickle cell anemia.[3] Gardos channel blockers may work in the treatment of sickle cell anemia by blocking the efflux of potassium and water from red blood cells, thereby preventing the dehydration of red blood cells and stopping the polymerization of HbS.

The Gardos channel has been identified as KCNN4.[4]

The "ICA" is for Icagen, which is developing the drug.[5]

References

Page Template:Reflist/styles.css has no content.

  1. ^ Page Module:Citation/CS1/styles.css has no content.Ataga KI, Smith WR, De Castro LM, et al. (April 2008). "Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia". Blood. 111 (8): 3991–7. doi:10.1182/blood-2007-08-110098. PMID 18192510.
  2. ^ Page Module:Citation/CS1/styles.css has no content.McNaughton-Smith GA, Burns JF, Stocker JW, et al. (February 2008). "Novel inhibitors of the Gardos channel for the treatment of sickle cell disease". J. Med. Chem. 51 (4): 976–82. doi:10.1021/jm070663s. PMID 18232633.
  3. ^ Page Module:Citation/CS1/styles.css has no content.Ataga KI; Stocker J (February 2009). "Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia". Expert Opin Investig Drugs. 18 (2): 231–9. doi:10.1517/13543780802708011. PMID 19236269. S2CID 73061898.
  4. ^ Page Module:Citation/CS1/styles.css has no content.Hoffman JF; Joiner W; Nehrke K; Potapova O; Foye K; Wickrema A (June 2003). "The hSK4 (KCNN4) isoform is the Ca2+-activated K+ channel (Gardos channel) in human red blood cells". Proc. Natl. Acad. Sci. U.S.A. 100 (12): 7366–71. Bibcode:2003PNAS..100.7366H. doi:10.1073/pnas.1232342100. PMC 165881. PMID 12773623.
  5. ^ Page Module:Citation/CS1/styles.css has no content."Icagen - Press Release". Retrieved 2008-12-22.


Template:Asbox

Retrieved from "https://cosmopedia.co/index.php?title=Senicapoc&oldid=6667916"